Are We Finally Close to Cannabis Reform? | TTB Presented by Flowhub

Introduction to the Podcast

Overview of Today's Discussion

• The podcast is hosted by Shad Dale, featuring a special guest, Dan from the Chart Guys, discussing recent movements in the psychedelics and cannabis sectors.

• Key topics include Compass Pathways, Definium Therapeutics, and the implications of an ATM announcement related to Tillray's dilution concerns.

Current Trends in Psychedelics and Cannabis

Industry Developments

• Recent headlines indicate progress towards federal legalization of cannabis; however, there is a call for action rather than just talk.

• The hosts reflect on their previous podcast with Christian, noting positive feedback and ongoing discussions about industry dynamics.

Personal Insights on Psychedelics

• The potential of psychedelics as a viable industry is emphasized; they are seen as beneficial for treating mental illnesses that traditional pharmaceuticals fail to address.

• Mental health issues are prevalent but often stigmatized; there's a strong belief in the need for effective treatments that can improve quality of life.

Investment Philosophy in Health Care

Ethical Considerations

• Investing should focus on companies that enhance people's lives rather than solely on profit; this aligns with advice from notable figures like Shaquille O'Neal.

• Acknowledgment of significant moments in healthcare history suggests optimism about future developments in treatment options for mental health.

Looking Ahead: Future Discussions

Upcoming Segments

• Transitioning into industry news segments before welcoming Dan from the Chart Guys to provide insights into market trends and analysis.

• The podcast emphasizes real-time inventory visibility and compliance reporting as critical components for serious cannabis operators.

FlowHub: Streamlining Cannabis Operations

Introduction to FlowHub

• FlowHub offers a unified platform for cannabis dispensaries, eliminating the need for multiple systems and manual processes. It aims to enhance operational efficiency as businesses scale from one location to multiple states.

• The platform emphasizes compliance and financial protection for dispensary owners, encouraging interested parties to book a demo at flowhub.com.

Federal Marijuana Reform Updates

• Recent news indicates that Congressman Hakeem Jeffries believes Congress has sufficient votes to pass federal marijuana reform, as reported by Marijuana Moment.

• The discussion highlights skepticism regarding the actual implementation of these reforms despite positive headlines; action is deemed more critical than mere announcements.

Political Dynamics

• The role of Speaker Mike Johnson in this legislative process raises questions about the feasibility of passing reform under current political conditions.

• There is cautious optimism among advocates like Jeffries, Booker, and Schumer who are pushing for cannabis discussions in Congress, but past experiences lead to skepticism about their effectiveness.

Industry Insights on Hemp Production

• USDA reports indicate that American farmers produced $739 million worth of legal hemp last year; however, this figure seems small compared to the $30 billion industry valuation.

• Questions arise regarding the source of additional biomass in the market since only a fraction appears legally produced; concerns include potential illicit sources or unregulated products entering legal channels.

Regulatory Considerations

• The conversation shifts towards regulation's impact on curtailing illegal markets and organized crime within the cannabis sector.

• Advocates emphasize that while supporting hemp growth is essential, it must be regulated similarly to THC products in order to ensure fair competition across both industries.

Conclusion on Hemp Regulation

• A call for parity between hemp and cannabis regulations is made; both should be treated equally under law due to their shared market dynamics involving THC products.

• Emphasis is placed on cohesive arguments advocating for regulatory frameworks that support both sectors without discrimination.

Cannabis Market Dynamics and Legalization Challenges

The Competition Between Hemp and Cannabis

• Discussion on the simplicity of market dynamics, highlighting that if hemp cannot compete, it indicates a lack of demand for intoxicating hemp products.

• Reference to the Canadian market where fully legalized cannabis exists alongside significant illegal cannabis operations, exemplified by a recent $5 million bust.

• Acknowledgment that while legalization may reduce the black market's profitability, it will not eliminate it entirely.

Illegal Cannabis Operations in Florida

• Clarification that there are no illegal shops in Florida; however, legal smoke shops sell intoxicating products.

• Description of illegal dispensaries operating out of rented apartments in Miami, resembling legitimate cannabis stores but selling illicit products.

• Comparison with New York's illegal dispensaries and mention of Florida's regulatory efforts to control hemp product proliferation.

Regulatory Framework and Market Impact

• Overview of Florida's recent regulations aimed at curbing unregulated hemp sales and their effectiveness remains uncertain.

• Mention of indigenous licenses being exploited by non-indigenous operators for dispensaries, indicating regulatory loopholes.

• Critique of Canadian government’s lack of attention to cannabis regulation since legalization nearly a decade ago.

Black Market Insights

• Highlighting the existence of a $3 billion black market in North Carolina due to absence of medical cannabis options.

Hemp vs. Cannabis: Regulatory Disparities

• Introduction to the conflict between intoxicating hemp lobbyists and state-regulated cannabis industries regarding consumer choice and anti-prohibition narratives.

• Emphasis on the need for parity between THC from both sources as they are chemically identical despite differing legal statuses.

Call for Regulation Reform

• Advocacy for regulated sales within markets that allow them, stressing that hemp sellers must acknowledge they are selling cannabis rather than farm bill compliant products.

• Recognition that discussions around regulation should focus on creating effective frameworks rather than delaying potential bans.

This structured summary captures key insights from the transcript while providing timestamps for easy reference.

Nicotine Pouches and Focus

Introduction to Free Pouch

• The speaker discusses the overwhelming nature of daily tasks, highlighting how a free nicotine pouch can enhance focus and productivity.

• Free Pouch offers clean nicotine delivery options ranging from 3mg to 15mg, allowing users to choose based on their day's intensity.

Promotional Offer

• A promotional code (TDR20) is provided for a 20% discount on purchases at freepouch.com.

Challenges in Cannabis Cash Flow

Financial Struggles for Cannabis Operators

• Licensed cannabis operators face cash flow issues despite selling products, often waiting up to 90 days for payment while needing to manage inventory and operational costs.

• Many operators unknowingly become lenders to their customers, which hampers business growth.

Fund Canada's Solutions

• Fund Canada provides capital tailored specifically for the cannabis industry, offering revolving lines of credit and upfront payment solutions.

• They have approved nearly $500 million in financing across over 5,000 transactions, emphasizing that their services align with the cash flow cycles of cannabis businesses.

Virginia's Cannabis Legislation Update

Legislative Developments

• Discussion about Virginia legislation regarding recreational cannabis sales; sponsors are urging colleagues to reject proposed amendments by Governor Abigail Spamberger.

• This situation indicates a willingness among sponsors to risk vetoing original measures for legislative integrity.

Implications of Potential Veto

• The potential veto could significantly impact market dynamics; there is hope for resolution as new markets are needed.

Political Predictions and Market Insights

Political Landscape Predictions

• A participant expresses confidence that Democrats will retain control of the House in upcoming elections despite differing opinions from others in the discussion.

Transitioning into Market Analysis

• The segment transitions into market analysis with Dan from Chart Guys joining the conversation after discussing political predictions.

Psychedelics Research and Stock Insights

Executive Orders Impacting Psychedelics

• Discussion on President Trump's executive order aimed at fast-tracking research into psychedelics alongside hints towards cannabis rescheduling.

Stock Market Focus: Compass Pathways

• Compass Pathways (CMPS), seen as a benchmark in the psychedelic space, experiences significant trading volume indicating investor interest.

Trading Strategies

• Dan shares his investment strategy involving long-term holds on CMPS while also engaging in short-term trades due to increased volatility.

Market Analysis and Support Levels

Current Market Conditions

• The speaker discusses the importance of setting higher lows and establishing new support levels, particularly around the $10 psychological level.

• A back test to hold support in the $8 range is desired, as this was previously a resistance point during price increases.

Biotech Sector Correlation

• The speaker notes that if support holds between the $5 and $6 marks, it could establish a floor around the $8 mark.

• There is a correlation between biotech stocks (represented by XBI ETF) and psychedelics; movements in one sector can influence the other.

Trading Strategies

• Emphasis on monitoring relative strength or weakness of individual stocks against their sectors due to automated trading systems linking various stocks together.

• The biotech sector's performance can sometimes stand out independently from macroeconomic factors, although news events can still impact trading significantly.

Impact of Interest Rates on Biotech Stocks

Interest Rate Sensitivity

• XBI reacts to interest rate rumors; changes in rates can greatly affect stock prices within this sector.

Recent Sector Performance

• ATI has shown significant growth (600% increase), but retraced 40%-50%, indicating volatility within the market.

• DFTX has emerged as a leading bull over recent months, showcasing strong upward movement without needing constant news updates.

Future Outlook for Psychedelic Stocks

Key Support Levels

• Monthly charts indicate tight ranges; breaking these could lead to further long-term bottoming or continued range-bound behavior depending on supply and demand dynamics.

Importance of Catalysts

• Continued headlines are crucial for maintaining relevance in the market. Positive catalysts like buyouts can uplift entire sectors, similar to past events with Canopy Growth.

Volume Trends and Market Sentiment

Volume Observations

• CN experienced high volume recently but saw an 80% drop afterward, indicating fluctuating investor interest.

Institutional vs. Retail Investors

• Discussion about whether institutional money is driving DFTX's growth despite lack of headlines; retail investors tend to react quickly to news.

Insights on the Psychedelic and Cannabis Investment Landscape

Market Trends in the Psychedelic Sector

• Key companies in the psychedelic space are showing steady growth over time, without significant spikes or pullbacks, indicating a stable market environment.

• The importance of strong support levels is highlighted; for instance, a critical support level at 1725 was defended by substantial buying activity from big money investors.

• Unlike the cannabis sector, which often lacks bid support to maintain price levels after headlines, psychedelics show more robust investor backing.

Comparing Psychedelics and Cannabis Investments

• The investment profiles differ significantly between psychedelics and cannabis; psychedelics attract serious investors looking for high returns based on biotech advancements.

• Investors in psychedelic stocks anticipate substantial returns due to potential pharmaceutical buyouts or successful drug market entries, contrasting with cannabis companies that operate more like consumer packaged goods (CPG).

• The comparison between these sectors is described as "apples to oranges," emphasizing their distinct business models and investor expectations.

Regulatory Developments Impacting Biotech

• Anticipation surrounds an NDA submission for Compass following two successful phase three trials, potentially expedited by recent executive orders aimed at streamlining processes.

• Retail investors face challenges due to slow-moving biotech developments but may find opportunities with upcoming FDA approvals that could accelerate growth.

Risk and Reward Dynamics in Biotech Investing

• High-risk investments in this sector can yield significant rewards; discussions highlight scenarios where investments could either plummet or soar dramatically based on data readouts and legal changes.

• A strategic approach involves allocating only a fraction of capital to these high-risk stocks while maintaining flexibility during uncertain events.

Challenges Facing the Cannabis Industry

• Discussion shifts to the cannabis industry with specific focus on Tillray's announcement of an $180 million ATM offering, raising concerns about dilution among investors.

• Historical context is provided regarding past experiences with dilution in penny stocks, underscoring its detrimental impact on stock performance despite promising narratives.

• Emphasis is placed on understanding share structure and dilution as critical factors influencing stock viability within both sectors.

This structured overview captures key insights from the discussion surrounding investment trends in both psychedelic and cannabis markets while highlighting regulatory impacts and risk considerations.

Market Dynamics and Stock Movements

Overview of Selling Pressure in Penny Stocks

• The discussion highlights that the primary sellers in penny stocks are companies themselves, which sell shares to raise capital during bullish market movements.

• Despite potential short squeezes and temporary price increases, these movements are deemed unsustainable due to an ongoing supply of shares.

Viewer Insights on Market Sentiment

• A viewer expresses confidence in a specific stock (Tillray), indicating a tendency among investors to only acknowledge information that aligns with their beliefs.

• The speaker suggests that taking a moment to consider different perspectives could be beneficial for investors.

ETF Performance Analysis

• Discussion shifts to the performance of the MSOS ETF, noting significant trading volume fluctuations over recent days.

• The speaker emphasizes the importance of maintaining momentum above key resistance levels, particularly around 435, as it indicates market health.

Technical Analysis and Market Trends

• The concept of "trenches" is introduced as a metaphor for support and resistance levels; breaking through these can signal market direction.

• If prices fail to hold above critical levels like 435, there may be a retracement back towards previous support zones.

Broader Market Context and Sentiment Shifts

• Observations are made about broader market trends where risk appetite has increased recently, leading to gains in previously underperforming stocks.

• There’s a call for concrete changes in policy or investment within sectors like cannabis and psychedelics to sustain interest from retail traders.

Challenges Facing Cannabis Sector

• The need for tangible progress beyond mere discussions is emphasized; rescheduling alone isn't sufficient without further developments.

• The speaker notes that while there’s been some attention on psychedelics recently, cannabis continues to struggle with attracting new buyers due to past hype cycles.

Investment Perspectives on Precious Metals

• Transitioning focus towards precious metals reveals opportunities amidst geopolitical tensions; silver shows signs of recovery after recent pullbacks.

• Personal experiences with trading silver highlight strategies involving trend analysis and managing positions based on market conditions.

Conclusion on Market Strategies

• Emphasis is placed on adapting strategies based on observed trends; setting stop-loss orders is crucial when entering trades near critical lows.

AI Semiconductors and Commodities: A Shift in Value?

The Current State of Currency and Commodities

• Discussion on the potential decline of the US dollar as the global currency, raising questions about market movements and underlying reasons.

• Reference to a book titled Listening When Markets Speak, suggesting that tangible assets are becoming more valuable in an environment where dollars can be printed infinitely.

• Personal anecdote about converting cryptocurrency gains into physical assets like real estate, food, and survival supplies, indicating a shift towards valuing tangibles over digital currencies.

Market Trends and Technical Analysis

• Concerns about future market pullbacks due to hyperinflation risks as more money is printed; highlights a growing trend towards investing in tangible goods.

• Technical analysis of commodity charts showing support levels and resistance points, indicating bullish trends despite recent dips.

• Explanation of inverse head-and-shoulders patterns in technical analysis as indicators for potential trend reversals from downtrends to uptrends.

Insights on Psychedelics and Cannabis Sectors

• Anticipation around developments in the psychedelic sector, with emphasis on FDA approvals for mental health therapies; suggests significant growth potential within this space over the next year.

• Caution advised for investors entering these sectors; emphasizes using amounts that won't cause psychological distress if there are significant drops in value.

Stock Recommendations and Market Sentiment

• Mention of specific stocks related to psychedelics such as DFTX (Definium Therapeutics), Compass Pathways (CMPS), and others; encourages diversification through ETFs rather than single stock investments.

• Discussion on cannabis stocks like YOLO (cannabis ETF); concerns raised regarding poor performance attributed to skepticism about revenue potential from CBD products.

Challenges Facing CBD Companies

• Insight into why CBD companies struggle financially; belief that anticipated revenue from Medicare pilots has not materialized as expected, leading to decreased investor confidence.

• Commentary on public perception regarding executive orders related to cannabis and psychedelics; suggests a lack of understanding among the masses about market dynamics.

Discussion on Cannabis and Psychedelics Coverage

Executive Orders and Public Perception

• The general public initially assumed that Trump's executive order on November 18th was about rescheduling cannabis, indicating a lack of understanding of the complexities involved.

• In contrast to cannabis, psychedelics received extensive media coverage from major outlets like CNN and the Washington Post, suggesting a disparity in public interest and awareness.

Media Coverage Comparison

• There is skepticism regarding whether cannabis will receive similar media attention when final rulings are published compared to psychedelics, with expectations for less fanfare.

Upcoming Discussions and Data Insights

• Whiz Buckley was scheduled to join but had a prior engagement; Kyle Sherman from Flowhub may discuss revenue data from 420 celebrations tomorrow.

• Anticipation builds around potential record-breaking revenue for 420 due to recent market trends.

Options Trading Landscape

• A segment on options trading will be featured tomorrow, focusing on both psychedelic and cannabis stocks in light of possible reforms. Viewers are encouraged to submit questions.

Market Dynamics in Psychedelics vs. Cannabis

Institutional Interest in Psychedelic Stocks

• Inquiry into JP Morgan's involvement with various cannabis companies indicates ongoing interest but lacks confirmation at this time.

Retail Trader Influence

• Discussion highlights that retail traders have not yet significantly impacted the psychedelic sector as they have with cannabis, which has seen multiple trading cycles.

Potential Market Reactions to FDA Approvals

• If drug development approvals occur (e.g., Compass), stock prices could surge dramatically within a short timeframe, contrasting with more gradual increases typically seen in other sectors.

Risks Associated with Biotech Investments

• The biotech industry is characterized by high volatility; successful drug approval can lead to significant gains while failure results in steep losses without middle ground.

Conclusion and Future Engagement

Viewer Engagement Encouragement

• The host invites viewers to provide feedback on the podcast episode and encourages them to return for future discussions at 4 PM daily.

Membership Promotion

• TDR Plus membership offers exclusive content including CEO interviews and insights from analysts for $7 per month, supporting the platform's operations.